Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> South Africa: Concern Over HIV Drug Trial
FDAnews Drug Daily Bulletin
June 12, 2012
| Vol. 9 No. 115
South Africa: Concern Over HIV Drug Trial
A proposed trial of an old antiretroviral drug, stavudine, which is no longer recommended due to its side-effects, has raised concern among AIDS activists who argue that its low cost is not enough reason to consider using it.
allAfrica
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Pharma Blog Watch
Drug Prices to Increase By 10 Percent
Enbrel and the Autoimmune Era
Briefs